Whey Protein Intake Modulates Lipid Metabolism by Transcriptionally Affecting PPARs and SREBP1c and Their Downstream Enzymes in Mice — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Whey Protein Intake Modulates Lipid Metabolism by Transcriptionally Affecting PPARs and SREBP1c and Their Downstream Enzymes in Mice
Department of Nutrition and Life Sciences, Kanagawa-Institute of Technology, Atsugi, Japan
1 Department of Nutrition and Life Sciences, Kanagawa-Institute of Technology, Atsugi, Japan
Background: The effects of whey protein intake on the transcriptional expression of genes related to lipid metabolism in mice were investigated herein. Methods: For 4 weeks, mice were fed AIN-93G composed of either casein or whey protein as the protein source. Then the gastrocnemius muscle, liver, and epididymal adipose tissue were excised. Expression levels of the transcription factors, PPAR <i> α </i> , PPAR <i> γ </i> , and SREBP1c, and those of the enzymes modulated by these factors, HSL, LPL, ACC <i> α </i> , and FAS, were measured by real-time PCR. The effects of whey protein were compared to those of the case in control. Results: The mRNA expression of PPAR <i> α </i> was enhanced in the gastrocnemius muscle, while that of PPAR <i> γ </i> was increased in the liver and epididymal adipose tissue. The expression of HSL and LPL was increased in the epididymal adipose tissue and gastrocnemius muscle, respectively. The mRNA expression of SREBP1c was suppressed in all of the three tissues. The expression of ACC <i> α </i> was suppressed in the gastrocnemius muscle and liver, while that of FAS was suppressed in all of the three tissues. Conclusions: These results indicate that whey protein intakes transcriptionally modulate PPARs and SREBP1c directing lipid metabolism toward the enhancement of triglyceride breakdown and suppression of fatty acid synthesis.
KeywordsWhey ProteinLipid MetabolismPPARsSREBP1c
Volek, J.S., Volk, B.M., Gómez, A.L., Kunces, L.J., Kupchak, B.R., Freidenreich, D.J., Aristizabal, J.C., Saenz, C., Dunn-Lewis, C., Ballard, K.D., Quann, E.E., Kawiecki, D.L., Flanagan, S.D., Comstock, B.A., Fragala, M.S., Earp, J.E., Fernandez, M.L., Bruno, R.S., Ptolemy, A.S., Kellogg, M.D., Maresh, C.M. and Kraemer, W.J. (2013) Whey Protein Supplementation during Resistance Training Augments Lean Body Mass. Journal of the American College of Nutrition, 32, 122-135. https://doi.org/10.1080/07315724.2013.793580
Cribb, P.J., Williams, A.D., Stathis, C.G., Carey, M.F. and Hayes, A. (2007) Effects of Whey Isolate, Creatine, and Resistance Training on Muscle Hypertrophy. Medicine and Science in Sports and Exercise, 39, 298-307. https://doi.org/10.1249/01.mss.0000247002.32589.ef
Dangin, M., Guillet, C., Garcia-Rodenas, C., Gachon, P., Bouteloup-Demange, C., Reiffers-Magnani, K., Fauquant, J., Ballèvre, O. and Beaufrère, B. (2003) The Rate of Protein Digestion Affects Protein Gain Differently during Aging in Humans. Journal of Physiology, 549, 635-644. https://doi.org/10.1113/jphysiol.2002.036897
Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C. and Glass, D.J. (2001) Akt/mTOR Pathway Is a Crucial Regulator of skeletal Muscle Hypertrophy and Can Prevent Muscle Atrophy in Vivo. Nature Cell Biology, 3, 1014-1019. https://doi.org/10.1038/ncb1101-1014
Farnfield, M.M., Carey, K.A., Gran, P., Trenerry, M.K. and Cameron-Smith, D. (2009) Whey Protein Ingestion Activates mTOR-Dependent Signaling after Resistance Exercise in Young Men: A Double-Blinded Randomized Controlled Trial. Nutrients, 1, 263-275. https://doi.org/10.3390/nu1020263
Baer, D.J., Stote, K.S., Paul, D.R., Harris, G.K., Rumpler, W.V. and Clevidence, B.A. (2011) Whey Protein But Not Soy Protein Supplementation Alters Body Weight and Composition in Free-Living Overweight and Obese Adults. Journal of Nutrition, 141, 1489-1494. https://doi.org/10.3945/jn.111.139840
Kume, H., Okazaki, K. and Sasaki, H. (2006) Hepatoprotective Effects of Whey Protein on D-Galactosamine-Induced Hepatitis and Liver Fibrosis in Rats. Bioscience, Biotechnology, and Biochemistry, 70, 1281-1285. https://doi.org/10.1271/bbb.70.1281
Kume, H., Okazaki, K., Yamaji, T. and Sasaki, H. (2012) A Newly Designed Enteral Formula Containing Whey Peptides and Fermented Milk Product Protects Mice against Concanavalin A-Induced Hepatitis by Suppressing Overproduction of Inflammatory Cytokines. Clinical Nutrition, 31, 283-289. https://doi.org/10.1016/j.clnu.2011.10.012
Sugawara, K., Takahashi, H., Sugawara, T., Yamada, K., Yanagida, S., Homma, M., Dairiki, K., Sasaki, H., Kawagoshi, A., Satake, M. and Shioya, T. (2012) Effect of Anti-Inflammatory Supplementation with Whey Peptide and Exercise Therapy in Patients with COPD. Respiratory Medicine, 106, 1526-1534. https://doi.org/10.1016/j.rmed.2012.07.001
Kaido, T., Ogura, Y., Ogawa, K., Hata, K., Yoshizawa, A., Yagi, S. and Uemoto, S. (2012) Effects of Post-Transplant Enteral Nutrition with an Immunomodulating Diet Containing Hydrolyzed Whey Peptide after Liver Transplantation. World Journal of Surgery, 36, 1666-1671. https://doi.org/10.1007/s00268-012-1529-9
Dalle, S., Rossmeislova, L. and Koppo, K. (2017) The Role of Inflammation in Age-Related Sarcopenia. Frontiers in Physiology, 8, 1045-1061. https://doi.org/10.3389/fphys.2017.01045
Umegaki, H. (2015) Sarcopenia and Diabetes: Hyperglycemia Is a Risk Factor for Age-Associated Muscle Mass and Functional Reduction. Journal of Diabetes Investigation, 6, 623-624. https://doi.org/10.1111/jdi.12365
Pani, G., Cavallucci, V. and Bartoccioni, E. (2016) Age-Related Sarcopenia: Diabetes of the Muscle? Journal of Clinical and Molecular Endocrinology, 1, 29-30.
Kreidieh, D., Itani, L., El Masri, D., Tannir, H., Citarella, R. and El Ghoch, M. (2018) Association between Sarcopenic Obesity, Type 2 Diabetes, and Hypertension in Overweight and Obese Treatment-Seeking Adult Women. Journal of Cardiovascular Development and Disease, 5, 51-58. https://doi.org/10.3390/jcdd5040051
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G.T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R.E.Jr., Kern, P.A. and Peterson, C.A. (2009) Muscle Inflammatory Response and Insulin Resistance: Synergistic Interaction between Macrophages and Fatty Acids Leads to Impaired Insulin Action. American Journal of Physiology: Endocrinology and Metabolism, 296, E1300-E1310. https://doi.org/10.1152/ajpendo.90885.2008
Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T. and Gonzalez, F.J. (1998) Altered Constitutive Expression of Fatty Acid-Metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-Activated Receptor α (PPARα). Journal of Biological Chemistry, 273, 5678-5684. https://doi.org/10.1074/jbc.273.10.5678
Kersten, S., Seydoux, J., Peters, J.M., Gonzalez, F.J., Desvergne, B. and Wahli, W. (1999) Peroxisome Proliferator-Activated Receptor α Mediates the Adaptive Response to Fasting. Journal of Clinical Investigation, 103, 1489-1498. https://doi.org/10.1172/JCI6223
Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A.M., Heyman, R.A., Briggs, M., Deeb, S., Staels, B. and Auwerx, J. (1996) PPARα and PPARγ Activators Direct a Distinct Tissue-Specific Transcriptional Response via a PPRE in the Lipoprotein Lipase Gene. EMBO Journal, 15, 5336-5348. https://doi.org/10.1002/j.1460-2075.1996.tb00918.x
Shen, W.J., Yu, Z., Patel, S., Jue, D., Liu, L.F. and Kraemer, F.B. (2011) Hormone-Sensitive Lipase Modulates Adipose Metabolism through PPARγ. Biochimica et Biophysica Acta, 1811, 9-16. https://doi.org/10.1016/j.bbalip.2010.10.001
Osborne, T.F. (2000) Sterol Regulatory Element-Binding Proteins (SREBPs): Key Regulators of Nutritional Homeostasis and Insulin Action. Journal of Biological Chemistry, 275, 32379-32382. https://doi.org/10.1074/jbc.R000017200
Eberlé, D., Hegarty, B., Bossard, P., Ferré, P. and Foufelle, F. (2004) SREBP Transcription Factors: Master Regulators of Lipid Homeostasis. Biochimie, 86, 839-848. https://doi.org/10.1016/j.biochi.2004.09.018
Inoue, H., Jiang, X.F., Katayama, T., Osada, S., Umesono, K. and Namura, S. (2003) Brain Protection by Resveratrol and Fenofibrate against Stroke Requires Peroxisome Proliferator-Activated Receptor Alpha in Mice. Neuroscience Letters, 352, 203-206. https://doi.org/10.1016/j.neulet.2003.09.001
Tsukamoto, T., Nakata, R., Tamura, E., Kosuge, Y., Kariya, A., Katsukawa, M., Mishima, S., Ito, T., Iinuma, M., Akao, Y., Nozawa, Y., Arai, A., Namura, S., Inoue, H. and Vaticanol, C.A. (2010) Resveratrol Tetramer Activates PPARα and PPARβ/δ in Vitro and in Vivo. Nutrition and Metabolism, 7, 46-53. https://doi.org/10.1186/1743-7075-7-46
Takizawa, Y., Nakata, R., Fukuhara, K., Yamashita, H., Kubodera, H. and Inoue, H. (2015) The 4’-Hydroxyl Group of Resveratrol Is Functionally Important for Direct Activation of PPARα. PLoS ONE, 10, e0120865. https://doi.org/10.1371/journal.pone.0120865
Calleri, E.., Pochetti, G., Dossou, K.S.S., Laghezza, A., Montanari, R., Capelli, D., Prada, E., Loiodice, F., Massolini, G., Bernier, M. and Moaddel, R. (2014) Resveratrol and Its Metabolites Bind to PPARs. ChemBioChem, 15, 1154-1160. https://doi.org/10.1002/cbic.201300754
Yamada, Y., Muraki, A., Oie, M., Kanegawa, N., Oda, A., Sawashi, Y., Kaneko, K., Yoshikawa, M., Goto, T., Takahashi, N., Kawada, T. and Ohinata, K. (2012) Soymorphin-5, a Soy-Derived μ-Opioid Peptide, Decreases Glucose and Triglyceride Levels through Activating Adiponectin and PPARα Systems in Diabetic KKAy Mice. American Journal of Physiology-Endocrinology and Metabolism, 302, E433-E440. https://doi.org/10.1152/ajpendo.00161.2011
Hashidume, T., Sasaki, T., Inoue, J. and Sato, R. (2011) Consumption of Soy Protein Isolate Reduces Hepatic SREBP-1c and Lipogenic Gene Expression in Wild-Type Mice, But Not in FXR-Deficient Mice. Bioscience, Biotechnology, and Biochemistry, 75, 1702-1707. https://doi.org/10.1271/bbb.110224